Table 2.
1 year follow-up (n=419)
|
2 year follow-up (n=369)
|
|||||||
---|---|---|---|---|---|---|---|---|
Integrated treatment (n=227) | Standard treatment (n=192) | Estimated mean difference (95% CI) | P value of difference | Integrated treatment (n=205) | Standard treatment (n=164) | Estimated mean difference (95% CI) | P value of difference | |
Psychopathology*: | ||||||||
Psychotic dimension | 1.09 (1.27) | 1.35 (1.39) | -0.31 (-0.55 to -0.07) | 0.02 | 1.06 (1.26) | 1.27 (1.40) | -0.32 (-0.58 to -0.06) | 0.02 |
Negative dimension | 1.68 (1.10) | 2.02 (1.12) | -0.36 (-0.54 to -0.17) | <0.001 | 1.41 (1.15) | 1.82 (1.23 | -0.45 (-0.67 to -0.22 | <0.001 |
Disorganised dimension | 0.40 (0.59) | 0.42 (0.56) | -0.04 (-0.14 to 0.07) | 0.5 | 0.37 (0.56) | 0.50 (0.73) | -0.12 (-0.25 to 0.00) | 0.06 |
GAF, symptom | 48.2 (14.9) | 44.9 (16.0) | 3.00 (0.37 to 5.63) | 0.03 | 51.18 (15.01) | 48.67 (15.92) | 2.45 (-0.32 to 5.22) | 0.08 |
GAF, function | 51.7 (15.1) | 49.4 (14.6) | 2.61 (0.11 to 5.15) | 0.04 | 55.16 (15.15) | 51.13 (15.92) | 3.12 (0.37 to 5.88) | 0.03 |
User satisfaction† | 24.9 (4.5) | 23.0 (7.2) | 1.88 (0.73 to 3.02) | 0.001 | 26.1 (3.7) | 22.9 (5.2) | 3.09 (2.10 to 4.04) | <0.001 |
GAF=global assessment of functioning.
Estimated mean differences are based on a repeated measurements model with treatment site, sex, substance misuse, diagnosis at baseline, and baseline values of the scale included as covariates (see text for details).
Based on client satisfaction questionnaire score. Estimated mean differences calculated by analysis of variance with treatment site as covariate.